Key result
Obesity-induced insulin resistance impairs LVAD-mediated myocardial recovery, but insulin sensitizers may improve outcomes.
Why the study?
Does insulin resistance impair LVAD-mediated myocardial recovery in obese patients with heart failure?
Does insulin resistance impair LVAD-mediated myocardial recovery in obese patients with heart failure?
Obesity-induced insulin resistance impairs the cardioprotective pentose phosphate pathway during LVAD unloading, suggesting insulin sensitizers could improve myocardial recovery in obese heart failure patients.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for insulin sensitization to aid LVAD recovery in obese HF; prospective trials needed before practice change.
In failing hearts, unloading leads to activation of insulin signaling, resulting in increased glucose uptake and an enhanced pentose phosphate pathway to protect cardiomyocytes against oxidative stress. However, this cardioprotective effect is attenuated by obesity-induced insulin resistance. Administration of insulin sensitizers has the potential to improve LVAD-mediated myocardial recovery in obese patients with HF.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question. Obesity-induced insulin resistance impairs LVAD-mediated myocardial recovery by compromising the pentose phosphate pathway, but insulin sensitizers may improve outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: